Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Rodondi

Showing results (51-60 of 531) with videos related to

Pageof 54
Sort By:
Circulation|May 31, 2018
Letter by Löwe et al Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up"Axel Lennart Löwe, Tinh-Hai Collet, Nicolas Rodondi
Revue Medicale Suisse|April 20, 2016
[New guidelines for screening and management of familial dyslipidemia]Nathalie Brun, Carole E Aubert, David Nanchen, et al.
European Heart Journal|March 23, 2017
Subclinical thyroid dysfunction and cardiovascular diseases: 2016 updateCarmen Floriani, Baris Gencer, Tinh-Hai Collet, et al.
Revue Medicale Suisse|April 5, 2012
[New european guidelines for dyslipidemia]Walter F Riesen, Vanessa Virgini, Bruno Vogt, et al.
Revue Medicale Suisse|April 20, 2016
[Is it possible to decrease cholesterol levels with dietary supplements?]Pierre-Yves Rodondi, Florence Degoumois, Pedro Marques-Vidal, et al.
Praxis|May 23, 2013
[Evidence based check-up: the general medical point of view]Christina Wirth, Zeno Stanga, Tanja Birrenbach, et al.
Revue Medicale Suisse|May 8, 2008
[Educational approach to patients with cardiovascular risk factors]Reto Auer, Diane Morin, Roger Darioli, et al.
The Journal of Clinical Endocrinology and Metabolism|April 8, 2017
Response to the Letter by ChoyLayal Chaker, Anne R Cappola, Nicolas Rodondi, et al.
Revue Medicale Suisse|March 11, 2015
[Statin treatment in primary and secondary prevention--a statement]François Mach, Walter F Riesen, Nicolas Rodondi, et al.
Journal of the American Geriatrics Society|August 22, 2012
Prefrailty and chronic morbidity in the youngest old: an insight from the Lausanne cohort Lc65+Nadia Danon-Hersch, Nicolas Rodondi, Jacques Spagnoli, et al.
Pageof 54

Showing results (51-60 of 531) with videos related to

Sort By:
Pageof 54
Circulation|May 31, 2018
Letter by Löwe et al Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up"Axel Lennart Löwe, Tinh-Hai Collet, Nicolas Rodondi
Revue Medicale Suisse|April 20, 2016
[New guidelines for screening and management of familial dyslipidemia]Nathalie Brun, Carole E Aubert, David Nanchen, et al.
European Heart Journal|March 23, 2017
Subclinical thyroid dysfunction and cardiovascular diseases: 2016 updateCarmen Floriani, Baris Gencer, Tinh-Hai Collet, et al.
Revue Medicale Suisse|April 5, 2012
[New european guidelines for dyslipidemia]Walter F Riesen, Vanessa Virgini, Bruno Vogt, et al.
Revue Medicale Suisse|April 20, 2016
[Is it possible to decrease cholesterol levels with dietary supplements?]Pierre-Yves Rodondi, Florence Degoumois, Pedro Marques-Vidal, et al.
Praxis|May 23, 2013
[Evidence based check-up: the general medical point of view]Christina Wirth, Zeno Stanga, Tanja Birrenbach, et al.
Revue Medicale Suisse|May 8, 2008
[Educational approach to patients with cardiovascular risk factors]Reto Auer, Diane Morin, Roger Darioli, et al.
The Journal of Clinical Endocrinology and Metabolism|April 8, 2017
Response to the Letter by ChoyLayal Chaker, Anne R Cappola, Nicolas Rodondi, et al.
Revue Medicale Suisse|March 11, 2015
[Statin treatment in primary and secondary prevention--a statement]François Mach, Walter F Riesen, Nicolas Rodondi, et al.
Journal of the American Geriatrics Society|August 22, 2012
Prefrailty and chronic morbidity in the youngest old: an insight from the Lausanne cohort Lc65+Nadia Danon-Hersch, Nicolas Rodondi, Jacques Spagnoli, et al.
Pageof 54